Transforming new markets into new opportunities

ISS EuropeA new age is dawning in the micro/nano-electronics industry as the use of ever more complex and capable chips is complemented by a developing demand for smart systems to fuel the Internet of Everything.

These market changes are driving a new era of industry value chains – extending beyond traditional semiconductor companies to the full ecosystem.

This growth has been accompanied by a massive influx of new applications intended to meet changing societal needs with cost-efficient electronic solutions; enabling intelligent mobility, future cities, smart power, and healthcare – to name but a few.

Outlined by Annastasiah Mudiwa Mhaka, director of Life Sciences, Johns Hopkins Medicine in the example when patients become more accountable for their health – from a shift toward prevention and seeking more personalized and decentralized care, including cost-efficient diagnostics and disease management interventions – the goal of the healthcare industry is to improve the patient experience of care, improve the health of populations, and reduce costs, the Triple Aim. However, as earnest the intent, escalating costs and marginal care improvements persist and are unsustainable. Four practices contribute to this unfavorable situation:

  • High demand for healthcare by consumers, particularly older patients with co-morbidities
  • Excessive use of expensive tools and interventions with too often unsubstantiated benefit
  • Fragmented and uncoordinated care
  • Under-utilization of state-of-the-art ICT

One method to impact cost/quality disparity issues, which has not been adequately explored, is the integration into healthcare of nanoelectronics. If utilized fully, nanoelectronics will bring the power of Moore’s law to medical practice – complex, small, inexpensive, and accurate consumer-friendly devices will connect to providers who will have on-demand access to patients’ medical histories, real-time information such as point-of-care blood testing, and related population intelligence to drive timely personalized treatment decisions. Patients will be able to meet virtually with their providers to work collaboratively to promote wellness, which will be a boon to providers and patients in low-resource settings, allowing them to benefit from high quality, cost-efficient care.

The innovation process will require cross-industry affiliation, collaborations with universities, healthcare providers, and regulators. If successful, it will reset how killer applications are identified; how building blocks relevant to nanomedicine are repurposed; how new platforms and tools are defined; and how computing and data methods to deliver quality care remotely and virtually are applied.

The next occasion to address global market and technology trends is SEMI’s Industry Strategy Symposium (ISS) Europe 2016 on March 6-8. The conference features prominent industry experts from across the supply chain and will offer a complete perspective of the changing business environment and evolving ecosystems within the electronics industry. Plan now to attend and be part of the strategic discussion.
Get a glimpse of what’s in store below and click here to see the full list of presenters at ISS Europe 2016.

  • Nissan Global Foundation: Haruyoshi Kumura, vice-chairman
  • NXP Netherlands: Maurice Geraets, member of the Board
  • Johns Hopkins Medicine: Annastasiah Mudiwa Mhaka, director of Life Sciences
  • Infineon Technologies AG: Arunjai Mittal, member of the Management Board
  • ASML: Rob Hartman, director, Strategic Technology Program
  • GLOBALFOUNDRIES: Rutger Wijjburg, senior VP and GM, Fab Management

Source: ISS Europe